Statins reduce mortality and failure to rescue after carotid artery stenting

Muhammad Rizwan1, Muhammad Faateh1, Hanaa Dakour-Aridi1

  • 1Division of Vascular Surgery, Department of Surgery, Johns Hopkins University Hospital, Baltimore, Md.

Insights

Statins significantly reduce mortality after carotid artery stenting (CAS), especially in patients experiencing complications like stroke or myocardial infarction (MI). These findings support encouraging statin use for all CAS patients.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Pharmacology

Background:

  • Statins are proven to reduce risks after carotid endarterectomy.
  • The impact of statins on patients undergoing carotid artery stenting (CAS) is not well understood.

Purpose of the Study:

  • To investigate the effect of statin use on postoperative outcomes in patients who underwent CAS.

Main Methods:

  • Retrospective analysis of the Premier Healthcare Database (2009-2015).
  • Inclusion of 17,800 patients undergoing CAS.
  • Statistical analysis using univariate and multivariate models to assess statin's impact on outcomes.

Main Results:

  • 70% of patients were on statins; this group had more comorbidities.
  • Statin use was linked to a 64% reduction in mortality (P < .001) and an 18% reduction in stroke/death (P = .03).
  • Statin users showed significantly lower mortality (failure to rescue) if stroke or MI occurred (11.4% vs 30.8%; P < .001).

Conclusions:

  • Statin use is associated with reduced mortality and improved outcomes in patients experiencing major complications post-CAS.
  • Strong recommendation for statin use in all patients undergoing CAS.
Abstract

Keywords:
CASStatins

Related Concept Videos

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
633
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.5K
Reducing Line Loss01:18

Reducing Line Loss

In a three-phase circuit, line loss is an indicator of energy dissipated as heat due to the resistance of transmission lines. To address this, incorporating transformers into the system—a step-up transformer at the source and a step-down transformer at the load—is a strategic solution. Two three-phase transformers are introduced to improve this.
With a step-up transformer at the source, the voltage is increased, thereby reducing the current in the transmission lines since power loss in...
390
Methods of reducing fever01:22

Methods of reducing fever

The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
1.4K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.9K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
927